News
While tianeptine is not listed in the federal Controlled Substances Act, which bans drugs like heroin and cocaine that have ...
U.S. cases of severe side effects from exposure to tianeptine have increased from 11 in total between 2000 and 2013 to 151 in ...
1d
Pharmaceutical Technology on MSNSupernus makes depression drug play with $795m Sage buyoutAfter Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.
I’d squirt the spray into my nose, where it’d drip to the back of my throat. The taste was potent: The office kept a dish of ...
Health officials want you to think twice before buying one of those brightly colored little bottles often sold at gas ...
A revolutionary treatment for severe adult depression is continuing to change lives in Northwest Kansas. Due to continued ...
Health 419 is the area’s first to administer treatments with Exomind, an updated transcranial magnetic stimulator ...
Strategic actions by Supernus, Teva, Incyte, and BioNTech highlight growing momentum in advancing clinical-stage therapies ...
Texas has moved to fund research into ibogaine, a psychedelic drug that may help treat addiction, depression and brain ...
Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results